Delivery of Ampoule, Psychotropic, Antibiotics Tender

• Country: Poland
• Summary: Delivery of Ampoule, Psychotropic, Antibiotics and Oncological Drugs in Drug and Chemotherapy for the Needs of Cozl.
• PLT Ref No: 119497469
• Deadline: 27 Jun 2025
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 326188-2025
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• The subject of the contract is: supply of ampoule, psychotropic, antibiotics and oncological drugs in drug and chemotherapy for the needs of COZL.
  Part 1 - canagphosin, ferrosi sulfas +ac. Folicum, Midazolam
  part 2 - cefiderocol
  part 3 - tuberculic vaccine
  part 4 -Paracetamol
  part 5 - Gentamycin
  part 6 - Desflurane
  part 7 - TIOTEPUM
  part 8 - Tremelimumab
  part 9 - Ixazomib
  part 10 - Darbopoethin Alfa
  part 11 - fludarabini phosphhas
  part 12 - Tenofovir disoproxil
  part 13 - Gefitinib
  part 14 - blinatumomab
  part 15 - part Nelarabina
  part 16 - Elotuzumab
  part17 - Anakinra
  part 18 - Tafasytamab
  part 19 - Tukatinib
  part 20 - Ramucirmabum
  part 21 - Eltombopag
  part 22 - Cladribine
  part 23 - Arsenia Trioxidum
  part 24 - nivolumab
  part 25 - ITatinib
  part 26 - bortezomib
  part 27 - abemaciclibum
  part 28 29 - binimethnib
  part 30- dabrafenib
  part 31 - pembrolyzumab
  part 32 - cetuximab
  part 33 - Encorafenib
  part 34 - axitinib
  part 35 - Palbocyclib
  part 36 - bosustynib
  part 37 - ropeginterferon
  part 38 - irinotecan
  part 39 - gemcitabina
  part 40 - part 41 - part 41 - part 41 - part 41 - part Cisplatina
  part 42 - paclitaxel
  part 43 -Daratumumab
  part 44 - APALUTAMID
  part 45 - Lenalidomid
  part 46 - Alpelisibum
  part 47 - etanercept
  part 48 - Sorafenib
  part 49 - Zanubrutinib
  part 50 - botulinum toxin a
  part 51 - Weemurafenib
  part 52 - Lanreotidum
  part 53 - part 53 - part 53 - part 53 - part Cabozantynib
  part 54 - ponatynibum
  part 55 - enzalutanib
  part5...
• Documents:

 Tender Notice